---
_id: '14543'
abstract:
- lang: eng
  text: The acyl-CoA-binding domain-containing protein 6 (ACBD6) is ubiquitously expressed,
    plays a role in the acylation of lipids and proteins, and regulates the N-myristoylation
    of proteins via N-myristoyltransferase enzymes (NMTs). However, its precise function
    in cells is still unclear, as is the consequence of ACBD6 defects on human pathophysiology.
    Utilizing exome sequencing and extensive international data sharing efforts, we
    identified 45 affected individuals from 28 unrelated families (consanguinity 93%)
    with bi-allelic pathogenic, predominantly loss-of-function (18/20) variants in
    ACBD6. We generated zebrafish and Xenopus tropicalis acbd6 knockouts by CRISPR/Cas9
    and characterized the role of ACBD6 on protein N-myristoylation with YnMyr chemical
    proteomics in the model organisms and human cells, with the latter also being
    subjected further to ACBD6 peroxisomal localization studies. The affected individuals
    (23 males and 22 females), with ages ranging from 1 to 50 years old, typically
    present with a complex and progressive disease involving moderate-to-severe global
    developmental delay/intellectual disability (100%) with significant expressive
    language impairment (98%), movement disorders (97%), facial dysmorphism (95%),
    and mild cerebellar ataxia (85%) associated with gait impairment (94%), limb spasticity/hypertonia
    (76%), oculomotor (71%) and behavioural abnormalities (65%), overweight (59%),
    microcephaly (39%) and epilepsy (33%). The most conspicuous and common movement
    disorder was dystonia (94%), frequently leading to early-onset progressive postural
    deformities (97%), limb dystonia (55%), and cervical dystonia (31%). A jerky tremor
    in the upper limbs (63%), a mild head tremor (59%), parkinsonism/hypokinesia developing
    with advancing age (32%), and simple motor and vocal tics were among other frequent
    movement disorders. Midline brain malformations including corpus callosum abnormalities
    (70%), hypoplasia/agenesis of the anterior commissure (66%), short midbrain and
    small inferior cerebellar vermis (38% each), as well as hypertrophy of the clava
    (24%) were common neuroimaging findings. acbd6-deficient zebrafish and Xenopus
    models effectively recapitulated many clinical phenotypes reported in patients
    including movement disorders, progressive neuromotor impairment, seizures, microcephaly,
    craniofacial dysmorphism, and midbrain defects accompanied by developmental delay
    with increased mortality over time. Unlike ACBD5, ACBD6 did not show a peroxisomal
    localisation and ACBD6-deficiency was not associated with altered peroxisomal
    parameters in patient fibroblasts. Significant differences in YnMyr-labelling
    were observed for 68 co- and 18 post-translationally N-myristoylated proteins
    in patient-derived fibroblasts. N-Myristoylation was similarly affected in acbd6-deficient
    zebrafish and Xenopus tropicalis models, including Fus, Marcks, and Chchd-related
    proteins implicated in neurological diseases. The present study provides evidence
    that bi-allelic pathogenic variants in ACBD6 lead to a distinct neurodevelopmental
    syndrome accompanied by complex and progressive cognitive and movement disorders.
article_number: awad380
article_processing_charge: No
article_type: original
author:
- first_name: Rauan
  full_name: Kaiyrzhanov, Rauan
  last_name: Kaiyrzhanov
- first_name: Aboulfazl
  full_name: Rad, Aboulfazl
  last_name: Rad
- first_name: Sheng-Jia
  full_name: Lin, Sheng-Jia
  last_name: Lin
- first_name: Aida
  full_name: Bertoli-Avella, Aida
  last_name: Bertoli-Avella
- first_name: Wouter W
  full_name: Kallemeijn, Wouter W
  last_name: Kallemeijn
- first_name: Annie
  full_name: Godwin, Annie
  last_name: Godwin
- first_name: Maha S
  full_name: Zaki, Maha S
  last_name: Zaki
- first_name: Kevin
  full_name: Huang, Kevin
  id: 3b3d2888-1ff6-11ee-9fa6-8f209ca91fe3
  last_name: Huang
  orcid: 0000-0002-2512-7812
- first_name: Tracy
  full_name: Lau, Tracy
  last_name: Lau
- first_name: Cassidy
  full_name: Petree, Cassidy
  last_name: Petree
- first_name: Stephanie
  full_name: Efthymiou, Stephanie
  last_name: Efthymiou
- first_name: Ehsan
  full_name: Ghayoor Karimiani, Ehsan
  last_name: Ghayoor Karimiani
- first_name: Maja
  full_name: Hempel, Maja
  last_name: Hempel
- first_name: Elizabeth A
  full_name: Normand, Elizabeth A
  last_name: Normand
- first_name: Sabine
  full_name: Rudnik-Schöneborn, Sabine
  last_name: Rudnik-Schöneborn
- first_name: Ulrich A
  full_name: Schatz, Ulrich A
  last_name: Schatz
- first_name: Marc P
  full_name: Baggelaar, Marc P
  last_name: Baggelaar
- first_name: Muhammad
  full_name: Ilyas, Muhammad
  last_name: Ilyas
- first_name: Tipu
  full_name: Sultan, Tipu
  last_name: Sultan
- first_name: Javeria Raza
  full_name: Alvi, Javeria Raza
  last_name: Alvi
- first_name: Manizha
  full_name: Ganieva, Manizha
  last_name: Ganieva
- first_name: Ben
  full_name: Fowler, Ben
  last_name: Fowler
- first_name: Ruxandra
  full_name: Aanicai, Ruxandra
  last_name: Aanicai
- first_name: Gulsen
  full_name: Akay Tayfun, Gulsen
  last_name: Akay Tayfun
- first_name: Abdulaziz
  full_name: Al Saman, Abdulaziz
  last_name: Al Saman
- first_name: Abdulrahman
  full_name: Alswaid, Abdulrahman
  last_name: Alswaid
- first_name: Nafise
  full_name: Amiri, Nafise
  last_name: Amiri
- first_name: Nilufar
  full_name: Asilova, Nilufar
  last_name: Asilova
- first_name: Vorasuk
  full_name: Shotelersuk, Vorasuk
  last_name: Shotelersuk
- first_name: Patra
  full_name: Yeetong, Patra
  last_name: Yeetong
- first_name: Matloob
  full_name: Azam, Matloob
  last_name: Azam
- first_name: Meisam
  full_name: Babaei, Meisam
  last_name: Babaei
- first_name: Gholamreza
  full_name: Bahrami Monajemi, Gholamreza
  last_name: Bahrami Monajemi
- first_name: Pouria
  full_name: Mohammadi, Pouria
  last_name: Mohammadi
- first_name: Saeed
  full_name: Samie, Saeed
  last_name: Samie
- first_name: Selina Husna
  full_name: Banu, Selina Husna
  last_name: Banu
- first_name: Jorge Pinto
  full_name: Basto, Jorge Pinto
  last_name: Basto
- first_name: Fanny
  full_name: Kortüm, Fanny
  last_name: Kortüm
- first_name: Mislen
  full_name: Bauer, Mislen
  last_name: Bauer
- first_name: Peter
  full_name: Bauer, Peter
  last_name: Bauer
- first_name: Christian
  full_name: Beetz, Christian
  last_name: Beetz
- first_name: Masoud
  full_name: Garshasbi, Masoud
  last_name: Garshasbi
- first_name: Awatif
  full_name: Hameed Issa, Awatif
  last_name: Hameed Issa
- first_name: Wafaa
  full_name: Eyaid, Wafaa
  last_name: Eyaid
- first_name: Hind
  full_name: Ahmed, Hind
  last_name: Ahmed
- first_name: Narges
  full_name: Hashemi, Narges
  last_name: Hashemi
- first_name: Kazem
  full_name: Hassanpour, Kazem
  last_name: Hassanpour
- first_name: Isabella
  full_name: Herman, Isabella
  last_name: Herman
- first_name: Sherozjon
  full_name: Ibrohimov, Sherozjon
  last_name: Ibrohimov
- first_name: Ban A
  full_name: Abdul-Majeed, Ban A
  last_name: Abdul-Majeed
- first_name: Maria
  full_name: Imdad, Maria
  last_name: Imdad
- first_name: Maksudjon
  full_name: Isrofilov, Maksudjon
  last_name: Isrofilov
- first_name: Qassem
  full_name: Kaiyal, Qassem
  last_name: Kaiyal
- first_name: Suliman
  full_name: Khan, Suliman
  last_name: Khan
- first_name: Brian
  full_name: Kirmse, Brian
  last_name: Kirmse
- first_name: Janet
  full_name: Koster, Janet
  last_name: Koster
- first_name: Charles Marques
  full_name: Lourenço, Charles Marques
  last_name: Lourenço
- first_name: Tadahiro
  full_name: Mitani, Tadahiro
  last_name: Mitani
- first_name: Oana
  full_name: Moldovan, Oana
  last_name: Moldovan
- first_name: David
  full_name: Murphy, David
  last_name: Murphy
- first_name: Maryam
  full_name: Najafi, Maryam
  last_name: Najafi
- first_name: Davut
  full_name: Pehlivan, Davut
  last_name: Pehlivan
- first_name: Maria Eugenia
  full_name: Rocha, Maria Eugenia
  last_name: Rocha
- first_name: Vincenzo
  full_name: Salpietro, Vincenzo
  last_name: Salpietro
- first_name: Miriam
  full_name: Schmidts, Miriam
  last_name: Schmidts
- first_name: Adel
  full_name: Shalata, Adel
  last_name: Shalata
- first_name: Mohammad
  full_name: Mahroum, Mohammad
  last_name: Mahroum
- first_name: Jawabreh Kassem
  full_name: Talbeya, Jawabreh Kassem
  last_name: Talbeya
- first_name: Robert W
  full_name: Taylor, Robert W
  last_name: Taylor
- first_name: Dayana
  full_name: Vazquez, Dayana
  last_name: Vazquez
- first_name: Annalisa
  full_name: Vetro, Annalisa
  last_name: Vetro
- first_name: Hans R
  full_name: Waterham, Hans R
  last_name: Waterham
- first_name: Mashaya
  full_name: Zaman, Mashaya
  last_name: Zaman
- first_name: Tina A
  full_name: Schrader, Tina A
  last_name: Schrader
- first_name: Wendy K
  full_name: Chung, Wendy K
  last_name: Chung
- first_name: Renzo
  full_name: Guerrini, Renzo
  last_name: Guerrini
- first_name: James R
  full_name: Lupski, James R
  last_name: Lupski
- first_name: Joseph
  full_name: Gleeson, Joseph
  last_name: Gleeson
- first_name: Mohnish
  full_name: Suri, Mohnish
  last_name: Suri
- first_name: Yalda
  full_name: Jamshidi, Yalda
  last_name: Jamshidi
- first_name: Kailash P
  full_name: Bhatia, Kailash P
  last_name: Bhatia
- first_name: Barbara
  full_name: Vona, Barbara
  last_name: Vona
- first_name: Michael
  full_name: Schrader, Michael
  last_name: Schrader
- first_name: Mariasavina
  full_name: Severino, Mariasavina
  last_name: Severino
- first_name: Matthew
  full_name: Guille, Matthew
  last_name: Guille
- first_name: Edward W
  full_name: Tate, Edward W
  last_name: Tate
- first_name: Gaurav K
  full_name: Varshney, Gaurav K
  last_name: Varshney
- first_name: Henry
  full_name: Houlden, Henry
  last_name: Houlden
- first_name: Reza
  full_name: Maroofian, Reza
  last_name: Maroofian
citation:
  ama: Kaiyrzhanov R, Rad A, Lin S-J, et al. Bi-allelic ACBD6 variants lead to a neurodevelopmental
    syndrome with progressive and complex movement disorders. <i>Brain</i>. 2023.
    doi:<a href="https://doi.org/10.1093/brain/awad380">10.1093/brain/awad380</a>
  apa: Kaiyrzhanov, R., Rad, A., Lin, S.-J., Bertoli-Avella, A., Kallemeijn, W. W.,
    Godwin, A., … Maroofian, R. (2023). Bi-allelic ACBD6 variants lead to a neurodevelopmental
    syndrome with progressive and complex movement disorders. <i>Brain</i>. Oxford
    University Press. <a href="https://doi.org/10.1093/brain/awad380">https://doi.org/10.1093/brain/awad380</a>
  chicago: Kaiyrzhanov, Rauan, Aboulfazl Rad, Sheng-Jia Lin, Aida Bertoli-Avella,
    Wouter W Kallemeijn, Annie Godwin, Maha S Zaki, et al. “Bi-Allelic ACBD6 Variants
    Lead to a Neurodevelopmental Syndrome with Progressive and Complex Movement Disorders.”
    <i>Brain</i>. Oxford University Press, 2023. <a href="https://doi.org/10.1093/brain/awad380">https://doi.org/10.1093/brain/awad380</a>.
  ieee: R. Kaiyrzhanov <i>et al.</i>, “Bi-allelic ACBD6 variants lead to a neurodevelopmental
    syndrome with progressive and complex movement disorders,” <i>Brain</i>. Oxford
    University Press, 2023.
  ista: Kaiyrzhanov R, Rad A, Lin S-J, Bertoli-Avella A, Kallemeijn WW, Godwin A,
    Zaki MS, Huang K, Lau T, Petree C, Efthymiou S, Ghayoor Karimiani E, Hempel M,
    Normand EA, Rudnik-Schöneborn S, Schatz UA, Baggelaar MP, Ilyas M, Sultan T, Alvi
    JR, Ganieva M, Fowler B, Aanicai R, Akay Tayfun G, Al Saman A, Alswaid A, Amiri
    N, Asilova N, Shotelersuk V, Yeetong P, Azam M, Babaei M, Bahrami Monajemi G,
    Mohammadi P, Samie S, Banu SH, Basto JP, Kortüm F, Bauer M, Bauer P, Beetz C,
    Garshasbi M, Hameed Issa A, Eyaid W, Ahmed H, Hashemi N, Hassanpour K, Herman
    I, Ibrohimov S, Abdul-Majeed BA, Imdad M, Isrofilov M, Kaiyal Q, Khan S, Kirmse
    B, Koster J, Lourenço CM, Mitani T, Moldovan O, Murphy D, Najafi M, Pehlivan D,
    Rocha ME, Salpietro V, Schmidts M, Shalata A, Mahroum M, Talbeya JK, Taylor RW,
    Vazquez D, Vetro A, Waterham HR, Zaman M, Schrader TA, Chung WK, Guerrini R, Lupski
    JR, Gleeson J, Suri M, Jamshidi Y, Bhatia KP, Vona B, Schrader M, Severino M,
    Guille M, Tate EW, Varshney GK, Houlden H, Maroofian R. 2023. Bi-allelic ACBD6
    variants lead to a neurodevelopmental syndrome with progressive and complex movement
    disorders. Brain., awad380.
  mla: Kaiyrzhanov, Rauan, et al. “Bi-Allelic ACBD6 Variants Lead to a Neurodevelopmental
    Syndrome with Progressive and Complex Movement Disorders.” <i>Brain</i>, awad380,
    Oxford University Press, 2023, doi:<a href="https://doi.org/10.1093/brain/awad380">10.1093/brain/awad380</a>.
  short: R. Kaiyrzhanov, A. Rad, S.-J. Lin, A. Bertoli-Avella, W.W. Kallemeijn, A.
    Godwin, M.S. Zaki, K. Huang, T. Lau, C. Petree, S. Efthymiou, E. Ghayoor Karimiani,
    M. Hempel, E.A. Normand, S. Rudnik-Schöneborn, U.A. Schatz, M.P. Baggelaar, M.
    Ilyas, T. Sultan, J.R. Alvi, M. Ganieva, B. Fowler, R. Aanicai, G. Akay Tayfun,
    A. Al Saman, A. Alswaid, N. Amiri, N. Asilova, V. Shotelersuk, P. Yeetong, M.
    Azam, M. Babaei, G. Bahrami Monajemi, P. Mohammadi, S. Samie, S.H. Banu, J.P.
    Basto, F. Kortüm, M. Bauer, P. Bauer, C. Beetz, M. Garshasbi, A. Hameed Issa,
    W. Eyaid, H. Ahmed, N. Hashemi, K. Hassanpour, I. Herman, S. Ibrohimov, B.A. Abdul-Majeed,
    M. Imdad, M. Isrofilov, Q. Kaiyal, S. Khan, B. Kirmse, J. Koster, C.M. Lourenço,
    T. Mitani, O. Moldovan, D. Murphy, M. Najafi, D. Pehlivan, M.E. Rocha, V. Salpietro,
    M. Schmidts, A. Shalata, M. Mahroum, J.K. Talbeya, R.W. Taylor, D. Vazquez, A.
    Vetro, H.R. Waterham, M. Zaman, T.A. Schrader, W.K. Chung, R. Guerrini, J.R. Lupski,
    J. Gleeson, M. Suri, Y. Jamshidi, K.P. Bhatia, B. Vona, M. Schrader, M. Severino,
    M. Guille, E.W. Tate, G.K. Varshney, H. Houlden, R. Maroofian, Brain (2023).
date_created: 2023-11-16T12:36:51Z
date_published: 2023-11-10T00:00:00Z
date_updated: 2023-11-20T10:17:32Z
day: '10'
department:
- _id: GradSch
doi: 10.1093/brain/awad380
extern: '1'
keyword:
- Neurology (clinical)
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://doi.org/10.1093/brain/awad380
month: '11'
oa: 1
oa_version: Submitted Version
publication: Brain
publication_identifier:
  eissn:
  - 1460-2156
  issn:
  - 0006-8950
publication_status: epub_ahead
publisher: Oxford University Press
quality_controlled: '1'
scopus_import: '1'
status: public
title: Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive
  and complex movement disorders
type: journal_article
user_id: 2DF688A6-F248-11E8-B48F-1D18A9856A87
year: '2023'
...
---
_id: '12174'
abstract:
- lang: eng
  text: "Vacuolar-type H+-ATPase (V-ATPase) is a multimeric complex present in a variety
    of cellular membranes that acts as an ATP-dependent proton pump and plays a key
    role in pH homeostasis and intracellular signalling pathways. In humans, 22 autosomal
    genes encode for a redundant set of subunits allowing the composition of diverse
    V-ATPase complexes with specific properties and expression. Sixteen subunits have
    been linked to human disease.\r\nHere we describe 26 patients harbouring 20 distinct
    pathogenic de novo missense ATP6V1A variants, mainly clustering within the ATP
    synthase α/β family-nucleotide-binding domain. At a mean age of 7 years (extremes:
    6 weeks, youngest deceased patient to 22 years, oldest patient) clinical pictures
    included early lethal encephalopathies with rapidly progressive massive brain
    atrophy, severe developmental epileptic encephalopathies and static intellectual
    disability with epilepsy. The first clinical manifestation was early hypotonia,
    in 70%; 81% developed epilepsy, manifested as developmental epileptic encephalopathies
    in 58% of the cohort and with infantile spasms in 62%; 63% of developmental epileptic
    encephalopathies failed to achieve any developmental, communicative or motor skills.
    Less severe outcomes were observed in 23% of patients who, at a mean age of 10
    years and 6 months, exhibited moderate intellectual disability, with independent
    walking and variable epilepsy. None of the patients developed communicative language.
    Microcephaly (38%) and amelogenesis imperfecta/enamel dysplasia (42%) were additional
    clinical features. Brain MRI demonstrated hypomyelination and generalized atrophy
    in 68%. Atrophy was progressive in all eight individuals undergoing repeated MRIs.</jats:p>\r\n
    \              <jats:p>Fibroblasts of two patients with developmental epileptic
    encephalopathies showed decreased LAMP1 expression, Lysotracker staining and increased
    organelle pH, consistent with lysosomal impairment and loss of V-ATPase function.
    Fibroblasts of two patients with milder disease, exhibited a different phenotype
    with increased Lysotracker staining, decreased organelle pH and no significant
    modification in LAMP1 expression. Quantification of substrates for lysosomal enzymes
    in cellular extracts from four patients revealed discrete accumulation. Transmission
    electron microscopy of fibroblasts of four patients with variable severity and
    of induced pluripotent stem cell-derived neurons from two patients with developmental
    epileptic encephalopathies showed electron-dense inclusions, lipid droplets, osmiophilic
    material and lamellated membrane structures resembling phospholipids. Quantitative
    assessment in induced pluripotent stem cell-derived neurons identified significantly
    smaller lysosomes.\r\nATP6V1A-related encephalopathy represents a new paradigm
    among lysosomal disorders. It results from a dysfunctional endo-lysosomal membrane
    protein causing altered pH homeostasis. Its pathophysiology implies intracellular
    accumulation of substrates whose composition remains unclear, and a combination
    of developmental brain abnormalities and neurodegenerative changes established
    during prenatal and early postanal development, whose severity is variably determined
    by specific pathogenic variants."
acknowledged_ssus:
- _id: EM-Fac
- _id: LifeSc
acknowledgement: "We thank all patients and family members for their participation
  in this study. We thank Melanie Pieraks and Eva Reinthaler (Neurolentech, Austria)
  for generating the human iPSC lines and\r\nfor performing quality checks. We thank
  Vanessa Zheden and Daniel Gütl for their excellent technical support in the specimen
  preparation for transmission electron microscopy and Flavia Leite for preparing
  the lentiviruses. The support from Electron Microscopy Facility and Molecular Biology
  Services at IST Austria is greatly acknowledged. We would like to thank Doctors
  Jane Hurst and Richard Scott for their help in retrieving the detailed clinical
  information of Patient 17. The research team acknowledges the support of the National
  Institute for Health Research, through the Comprehensive Clinical Research Network.
  See Supplementary Material for Undiagnosed Disease Network consortium details. Genetic
  information on Patient 23 was made available through access to the data and findings
  generated by the 100 000 Genomes\r\nProject; www.genomicsengland.co.uk (to K.L.).
  \r\nThis work was supported by the EU 7th Framework Programme (FP7) under the project
  DESIRE grant N602531 (to R.G.); the Regione Toscana under the Call for Health 2018
  (grant\r\nDECODE-EE) (to R.G.); the ‘Brain Project’ by Fondazione Cassa di Risparmio
  di Firenze (to R.G.); IRCCS Ospedale Policlinico San Martino 5×1000 and Ricerca
  Corrente (to A.F. and F.B.). The European Reference Network (ERN) for rare and complex
  epilepsies (EpiCARE) provided financial support for meetings organization. The DDD
  study presents independent research commissioned by the Health Innovation Challenge
  Fund (grant number HICF-1009-003), a parallel funding partnership between Wellcome
  and the Department of Health, and the Wellcome Sanger Institute (grant number WT098051).
  The views expressed in this publication\r\nare those of the author(s) and not necessarily
  those of Wellcome or the Department of Health. The study has UK Research Ethics
  Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12
  granted by the Republic of Ireland REC). This study makes use of DECIPHER (https://www.deciphergenomics.org),
  which is funded by Wellcome. K.K.-S. was supported by the ISTplus fellowship. "
article_processing_charge: No
article_type: original
author:
- first_name: Renzo
  full_name: Guerrini, Renzo
  last_name: Guerrini
- first_name: Davide
  full_name: Mei, Davide
  last_name: Mei
- first_name: Margit Katalin
  full_name: Szigeti, Margit Katalin
  id: 44F4BDC0-F248-11E8-B48F-1D18A9856A87
  last_name: Szigeti
  orcid: 0000-0001-9500-8758
- first_name: Sara
  full_name: Pepe, Sara
  last_name: Pepe
- first_name: Mary Kay
  full_name: Koenig, Mary Kay
  last_name: Koenig
- first_name: Gretchen
  full_name: Von Allmen, Gretchen
  last_name: Von Allmen
- first_name: Megan T
  full_name: Cho, Megan T
  last_name: Cho
- first_name: Kimberly
  full_name: McDonald, Kimberly
  last_name: McDonald
- first_name: Janice
  full_name: Baker, Janice
  last_name: Baker
- first_name: Vikas
  full_name: Bhambhani, Vikas
  last_name: Bhambhani
- first_name: Zöe
  full_name: Powis, Zöe
  last_name: Powis
- first_name: Lance
  full_name: Rodan, Lance
  last_name: Rodan
- first_name: Rima
  full_name: Nabbout, Rima
  last_name: Nabbout
- first_name: Giulia
  full_name: Barcia, Giulia
  last_name: Barcia
- first_name: Jill A
  full_name: Rosenfeld, Jill A
  last_name: Rosenfeld
- first_name: Carlos A
  full_name: Bacino, Carlos A
  last_name: Bacino
- first_name: Cyril
  full_name: Mignot, Cyril
  last_name: Mignot
- first_name: Lillian H
  full_name: Power, Lillian H
  last_name: Power
- first_name: Catharine J
  full_name: Harris, Catharine J
  last_name: Harris
- first_name: Dragan
  full_name: Marjanovic, Dragan
  last_name: Marjanovic
- first_name: Rikke S
  full_name: Møller, Rikke S
  last_name: Møller
- first_name: Trine B
  full_name: Hammer, Trine B
  last_name: Hammer
- first_name: Riikka
  full_name: Keski Filppula, Riikka
  last_name: Keski Filppula
- first_name: Päivi
  full_name: Vieira, Päivi
  last_name: Vieira
- first_name: Clara
  full_name: Hildebrandt, Clara
  last_name: Hildebrandt
- first_name: Stephanie
  full_name: Sacharow, Stephanie
  last_name: Sacharow
- first_name: Luca
  full_name: Maragliano, Luca
  last_name: Maragliano
- first_name: Fabio
  full_name: Benfenati, Fabio
  last_name: Benfenati
- first_name: Katherine
  full_name: Lachlan, Katherine
  last_name: Lachlan
- first_name: Andreas
  full_name: Benneche, Andreas
  last_name: Benneche
- first_name: Florence
  full_name: Petit, Florence
  last_name: Petit
- first_name: Jean Madeleine
  full_name: de Sainte Agathe, Jean Madeleine
  last_name: de Sainte Agathe
- first_name: Barbara
  full_name: Hallinan, Barbara
  last_name: Hallinan
- first_name: Yue
  full_name: Si, Yue
  last_name: Si
- first_name: Ingrid M
  full_name: Wentzensen, Ingrid M
  last_name: Wentzensen
- first_name: Fanggeng
  full_name: Zou, Fanggeng
  last_name: Zou
- first_name: Vinodh
  full_name: Narayanan, Vinodh
  last_name: Narayanan
- first_name: Naomichi
  full_name: Matsumoto, Naomichi
  last_name: Matsumoto
- first_name: Alessandra
  full_name: Boncristiano, Alessandra
  last_name: Boncristiano
- first_name: Giancarlo
  full_name: la Marca, Giancarlo
  last_name: la Marca
- first_name: Mitsuhiro
  full_name: Kato, Mitsuhiro
  last_name: Kato
- first_name: Kristin
  full_name: Anderson, Kristin
  last_name: Anderson
- first_name: Carmen
  full_name: Barba, Carmen
  last_name: Barba
- first_name: Luisa
  full_name: Sturiale, Luisa
  last_name: Sturiale
- first_name: Domenico
  full_name: Garozzo, Domenico
  last_name: Garozzo
- first_name: Roberto
  full_name: Bei, Roberto
  last_name: Bei
- first_name: Laura
  full_name: Masuelli, Laura
  last_name: Masuelli
- first_name: Valerio
  full_name: Conti, Valerio
  last_name: Conti
- first_name: Gaia
  full_name: Novarino, Gaia
  id: 3E57A680-F248-11E8-B48F-1D18A9856A87
  last_name: Novarino
  orcid: 0000-0002-7673-7178
- first_name: Anna
  full_name: Fassio, Anna
  last_name: Fassio
citation:
  ama: 'Guerrini R, Mei D, Szigeti MK, et al. Phenotypic and genetic spectrum of ATP6V1A
    encephalopathy: A disorder of lysosomal homeostasis. <i>Brain</i>. 2022;145(8):2687-2703.
    doi:<a href="https://doi.org/10.1093/brain/awac145">10.1093/brain/awac145</a>'
  apa: 'Guerrini, R., Mei, D., Szigeti, M. K., Pepe, S., Koenig, M. K., Von Allmen,
    G., … Fassio, A. (2022). Phenotypic and genetic spectrum of ATP6V1A encephalopathy:
    A disorder of lysosomal homeostasis. <i>Brain</i>. Oxford University Press. <a
    href="https://doi.org/10.1093/brain/awac145">https://doi.org/10.1093/brain/awac145</a>'
  chicago: 'Guerrini, Renzo, Davide Mei, Margit Katalin Szigeti, Sara Pepe, Mary Kay
    Koenig, Gretchen Von Allmen, Megan T Cho, et al. “Phenotypic and Genetic Spectrum
    of ATP6V1A Encephalopathy: A Disorder of Lysosomal Homeostasis.” <i>Brain</i>.
    Oxford University Press, 2022. <a href="https://doi.org/10.1093/brain/awac145">https://doi.org/10.1093/brain/awac145</a>.'
  ieee: 'R. Guerrini <i>et al.</i>, “Phenotypic and genetic spectrum of ATP6V1A encephalopathy:
    A disorder of lysosomal homeostasis,” <i>Brain</i>, vol. 145, no. 8. Oxford University
    Press, pp. 2687–2703, 2022.'
  ista: 'Guerrini R, Mei D, Szigeti MK, Pepe S, Koenig MK, Von Allmen G, Cho MT, McDonald
    K, Baker J, Bhambhani V, Powis Z, Rodan L, Nabbout R, Barcia G, Rosenfeld JA,
    Bacino CA, Mignot C, Power LH, Harris CJ, Marjanovic D, Møller RS, Hammer TB,
    Keski Filppula R, Vieira P, Hildebrandt C, Sacharow S, Maragliano L, Benfenati
    F, Lachlan K, Benneche A, Petit F, de Sainte Agathe JM, Hallinan B, Si Y, Wentzensen
    IM, Zou F, Narayanan V, Matsumoto N, Boncristiano A, la Marca G, Kato M, Anderson
    K, Barba C, Sturiale L, Garozzo D, Bei R, Masuelli L, Conti V, Novarino G, Fassio
    A. 2022. Phenotypic and genetic spectrum of ATP6V1A encephalopathy: A disorder
    of lysosomal homeostasis. Brain. 145(8), 2687–2703.'
  mla: 'Guerrini, Renzo, et al. “Phenotypic and Genetic Spectrum of ATP6V1A Encephalopathy:
    A Disorder of Lysosomal Homeostasis.” <i>Brain</i>, vol. 145, no. 8, Oxford University
    Press, 2022, pp. 2687–703, doi:<a href="https://doi.org/10.1093/brain/awac145">10.1093/brain/awac145</a>.'
  short: R. Guerrini, D. Mei, M.K. Szigeti, S. Pepe, M.K. Koenig, G. Von Allmen, M.T.
    Cho, K. McDonald, J. Baker, V. Bhambhani, Z. Powis, L. Rodan, R. Nabbout, G. Barcia,
    J.A. Rosenfeld, C.A. Bacino, C. Mignot, L.H. Power, C.J. Harris, D. Marjanovic,
    R.S. Møller, T.B. Hammer, R. Keski Filppula, P. Vieira, C. Hildebrandt, S. Sacharow,
    L. Maragliano, F. Benfenati, K. Lachlan, A. Benneche, F. Petit, J.M. de Sainte
    Agathe, B. Hallinan, Y. Si, I.M. Wentzensen, F. Zou, V. Narayanan, N. Matsumoto,
    A. Boncristiano, G. la Marca, M. Kato, K. Anderson, C. Barba, L. Sturiale, D.
    Garozzo, R. Bei, L. Masuelli, V. Conti, G. Novarino, A. Fassio, Brain 145 (2022)
    2687–2703.
date_created: 2023-01-12T12:11:45Z
date_published: 2022-08-01T00:00:00Z
date_updated: 2023-08-04T09:13:08Z
day: '01'
department:
- _id: GaNo
doi: 10.1093/brain/awac145
ec_funded: 1
external_id:
  isi:
  - '000807770000001'
intvolume: '       145'
isi: 1
issue: '8'
keyword:
- Neurology (clinical)
language:
- iso: eng
main_file_link:
- open_access: '1'
  url: https://doi.org/10.1093/brain/awac145
month: '08'
oa: 1
oa_version: Published Version
page: 2687-2703
project:
- _id: 260C2330-B435-11E9-9278-68D0E5697425
  call_identifier: H2020
  grant_number: '754411'
  name: ISTplus - Postdoctoral Fellowships
publication: Brain
publication_identifier:
  eissn:
  - 1460-2156
  issn:
  - 0006-8950
publication_status: published
publisher: Oxford University Press
quality_controlled: '1'
scopus_import: '1'
status: public
title: 'Phenotypic and genetic spectrum of ATP6V1A encephalopathy: A disorder of lysosomal
  homeostasis'
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 145
year: '2022'
...
---
_id: '12212'
abstract:
- lang: eng
  text: Alzheimer’s disease (AD) is characterized by a reorganization of brain activity
    determining network hyperexcitability and loss of synaptic plasticity. Precisely,
    a dysfunction in metabotropic GABAB receptor signalling through G protein-gated
    inwardly rectifying K+ (GIRK or Kir3) channels on the hippocampus has been postulated.
    Thus, we determined the impact of amyloid-β (Aβ) pathology in GIRK channel density,
    subcellular distribution, and its association with GABAB receptors in hippocampal
    CA1 pyramidal neurons from the APP/PS1 mouse model using quantitative SDS-digested
    freeze-fracture replica labelling (SDS-FRL) and proximity ligation in situ assay
    (P-LISA). In wild type mice, single SDS-FRL detection revealed a similar dendritic
    gradient for GIRK1 and GIRK2 in CA1 pyramidal cells, with higher densities in
    spines, and GIRK3 showed a lower and uniform distribution. Double SDS-FRL showed
    a co-clustering of GIRK2 and GIRK1 in post- and presynaptic compartments, but
    not for GIRK2 and GIRK3. Likewise, double GABAB1 and GIRK2 SDS-FRL detection displayed
    a high degree of co-clustering in nanodomains (40–50 nm) mostly in spines and
    axon terminals. In APP/PS1 mice, the density of GIRK2 and GIRK1, but not for GIRK3,
    was significantly reduced along the neuronal surface of CA1 pyramidal cells and
    in axon terminals contacting them. Importantly, GABAB1 and GIRK2 co-clustering
    was not present in APP/PS1 mice. Similarly, P-LISA experiments revealed a significant
    reduction in GABAB1 and GIRK2 interaction on the hippocampus of this animal model.
    Overall, our results provide compelling evidence showing a significant reduction
    on the cell surface density of pre- and postsynaptic GIRK1 and GIRK2, but not
    GIRK3, and a decline in GABAB receptors and GIRK2 channels co-clustering in hippocampal
    pyramidal neurons from APP/PS1 mice, thus suggesting that a disruption in the
    GABAB receptor–GIRK channel membrane assembly causes dysregulation in the GABAB
    signalling via GIRK channels in this AD animal model.
acknowledgement: "We thank Ms. Diane Latawiec for the English revision of the manuscript.
  Funding sources were the Spanish Ministerio de Economía y Competitividad, Junta
  de Comunidades de Castilla-La Mancha (Spain), and Life Science Innovation Center
  at University of Fukui. We thank Centres de Recerca de Catalunya (CERCA) Programme/Generalitat
  de Catalunya for IDIBELL institutional support. We thank Hitoshi Takagi and Takako
  Maegawa at the University of Fukui for their technical assistance on SDS-FRL experiments.\r\nThis
  work was supported by grants from the Spanish Ministerio de Economía y Competitividad
  (BFU2015-63769-R, RTI2018-095812-B-I00, and PID2021-125875OB-I00) and Junta de Comunidades
  de Castilla-La Mancha (SBPLY/17/180501/000229 and SBPLY/21/180501/000064) to RL,
  Life Science Innovation Center at University of Fukui and JSPS KAKENHI (Grant Numbers
  16H04662, 19H03323, and 20H05058) to YF, and Margarita Salas fellowship from Ministerio
  de Universidades and Universidad de Castilla-La Mancha to AMB."
article_number: '136'
article_processing_charge: No
article_type: original
author:
- first_name: Alejandro
  full_name: Martín-Belmonte, Alejandro
  last_name: Martín-Belmonte
- first_name: Carolina
  full_name: Aguado, Carolina
  last_name: Aguado
- first_name: Rocío
  full_name: Alfaro-Ruiz, Rocío
  last_name: Alfaro-Ruiz
- first_name: Ana Esther
  full_name: Moreno-Martínez, Ana Esther
  last_name: Moreno-Martínez
- first_name: Luis
  full_name: de la Ossa, Luis
  last_name: de la Ossa
- first_name: Ester
  full_name: Aso, Ester
  last_name: Aso
- first_name: Laura
  full_name: Gómez-Acero, Laura
  last_name: Gómez-Acero
- first_name: Ryuichi
  full_name: Shigemoto, Ryuichi
  id: 499F3ABC-F248-11E8-B48F-1D18A9856A87
  last_name: Shigemoto
  orcid: 0000-0001-8761-9444
- first_name: Yugo
  full_name: Fukazawa, Yugo
  last_name: Fukazawa
- first_name: Francisco
  full_name: Ciruela, Francisco
  last_name: Ciruela
- first_name: Rafael
  full_name: Luján, Rafael
  last_name: Luján
citation:
  ama: Martín-Belmonte A, Aguado C, Alfaro-Ruiz R, et al. Nanoscale alterations in
    GABAB receptors and GIRK channel organization on the hippocampus of APP/PS1 mice.
    <i>Alzheimer’s Research &#38; Therapy</i>. 2022;14. doi:<a href="https://doi.org/10.1186/s13195-022-01078-5">10.1186/s13195-022-01078-5</a>
  apa: Martín-Belmonte, A., Aguado, C., Alfaro-Ruiz, R., Moreno-Martínez, A. E., de
    la Ossa, L., Aso, E., … Luján, R. (2022). Nanoscale alterations in GABAB receptors
    and GIRK channel organization on the hippocampus of APP/PS1 mice. <i>Alzheimer’s
    Research &#38; Therapy</i>. Springer Nature. <a href="https://doi.org/10.1186/s13195-022-01078-5">https://doi.org/10.1186/s13195-022-01078-5</a>
  chicago: Martín-Belmonte, Alejandro, Carolina Aguado, Rocío Alfaro-Ruiz, Ana Esther
    Moreno-Martínez, Luis de la Ossa, Ester Aso, Laura Gómez-Acero, et al. “Nanoscale
    Alterations in GABAB Receptors and GIRK Channel Organization on the Hippocampus
    of APP/PS1 Mice.” <i>Alzheimer’s Research &#38; Therapy</i>. Springer Nature,
    2022. <a href="https://doi.org/10.1186/s13195-022-01078-5">https://doi.org/10.1186/s13195-022-01078-5</a>.
  ieee: A. Martín-Belmonte <i>et al.</i>, “Nanoscale alterations in GABAB receptors
    and GIRK channel organization on the hippocampus of APP/PS1 mice,” <i>Alzheimer’s
    Research &#38; Therapy</i>, vol. 14. Springer Nature, 2022.
  ista: Martín-Belmonte A, Aguado C, Alfaro-Ruiz R, Moreno-Martínez AE, de la Ossa
    L, Aso E, Gómez-Acero L, Shigemoto R, Fukazawa Y, Ciruela F, Luján R. 2022. Nanoscale
    alterations in GABAB receptors and GIRK channel organization on the hippocampus
    of APP/PS1 mice. Alzheimer’s Research &#38; Therapy. 14, 136.
  mla: Martín-Belmonte, Alejandro, et al. “Nanoscale Alterations in GABAB Receptors
    and GIRK Channel Organization on the Hippocampus of APP/PS1 Mice.” <i>Alzheimer’s
    Research &#38; Therapy</i>, vol. 14, 136, Springer Nature, 2022, doi:<a href="https://doi.org/10.1186/s13195-022-01078-5">10.1186/s13195-022-01078-5</a>.
  short: A. Martín-Belmonte, C. Aguado, R. Alfaro-Ruiz, A.E. Moreno-Martínez, L. de
    la Ossa, E. Aso, L. Gómez-Acero, R. Shigemoto, Y. Fukazawa, F. Ciruela, R. Luján,
    Alzheimer’s Research &#38; Therapy 14 (2022).
date_created: 2023-01-16T09:45:51Z
date_published: 2022-09-21T00:00:00Z
date_updated: 2023-08-04T09:23:10Z
day: '21'
ddc:
- '570'
department:
- _id: RySh
doi: 10.1186/s13195-022-01078-5
external_id:
  isi:
  - '000857985500001'
file:
- access_level: open_access
  checksum: 88e49715ad6a1abf0fdb27efd65368dc
  content_type: application/pdf
  creator: dernst
  date_created: 2023-01-27T07:53:18Z
  date_updated: 2023-01-27T07:53:18Z
  file_id: '12413'
  file_name: 2022_AlzheimersResearch_MartinBelmont.pdf
  file_size: 11013325
  relation: main_file
  success: 1
file_date_updated: 2023-01-27T07:53:18Z
has_accepted_license: '1'
intvolume: '        14'
isi: 1
keyword:
- Cognitive Neuroscience
- Neurology (clinical)
- Neurology
language:
- iso: eng
month: '09'
oa: 1
oa_version: Published Version
publication: Alzheimer's Research & Therapy
publication_identifier:
  issn:
  - 1758-9193
publication_status: published
publisher: Springer Nature
quality_controlled: '1'
scopus_import: '1'
status: public
title: Nanoscale alterations in GABAB receptors and GIRK channel organization on the
  hippocampus of APP/PS1 mice
tmp:
  image: /images/cc_by.png
  legal_code_url: https://creativecommons.org/licenses/by/4.0/legalcode
  name: Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
  short: CC BY (4.0)
type: journal_article
user_id: 4359f0d1-fa6c-11eb-b949-802e58b17ae8
volume: 14
year: '2022'
...
